November 05, 2012 at 07:00 AM EST
Alzheimer Drug Research Continues Despite Setbacks; New UCLA Study Says 1M Californians Lost Job-Based Health Care in Recession - Health Minute for November 5, 2012

SOURCE: 3BL Media, LLC

DESCRIPTION:

A new report has found that Alzheimer’s drug research has resulted in only three drugs brought to market out of 101 drugs that were in development to treat the disease over the last 13 years. The study, by the Pharmaceutical Research and Manufacturers of America, also notes that there are 93 new meds in the pipeline, and that biopharma shows no signs of letting up in the hunt for treatments against Alzheimer’s, which afflicts five million Americans who currently have access to only five approved drugs for symptoms of the disease.

 

More than one million Californians have lost job-based health insurance during the recession, according to a new study from the UCLA Center for Health Policy Research. The percentage of Californians who had insurance through their own or a family member’s employment fell below 50 percent for the first time in ten years. The report also found that the percentage of non-elderly adults and children enrolled in Medi-Cal and the state’s Healthy Families program increased, with one in five insured through these public health insurance program for low-income Californians.

 

For more information on these and other stories, go to 3blmedia.com

 

Video Source: Alzheimer Drug Research Continues Despite Setbacks; New UCLA Study Says 1M Californians Lost Job-Based Health Care in Recession

Tweet me: #Alzheimer drug research continues; New @UCLA study says 1M Californians Lost Job-Based #healthcare in Recession http://3bl.me/se5x4d

KEYWORDS: Alzheimer, Drug Research, UCLA, California, Healthcare, jobs, Recession, Health, Health Minute, 3bl Media

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here